Subventions financées

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no known cure, leading to progressive loss of motor function and ultimately death.

The understanding of the factors responsible for the increased risk of cognitive problems in women remains limited.

Concussions frequently occur worldwide, with a subset of patients experiencing lasting symptoms impacting their quality of life.

Challenge: Alzheimer’s disease (AD) is characterized by a decline in cognitive function, yet it is now widely acknowledged that as the disease advances, dopaminergic neurons in the midbrain become particularly vulnerable, leading to non-cognitive symptoms such as motor dysfunction.

Amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig’s Disease, is a neurodegenerative disease for which there is no effective treatment.

It is not known why ALS is a rapidly progressing disease.

Within the brain, cells communicate by sending signals that either enhance or dampen the activity of other cells.

When a person suffers a severe brain injury, whether from an accident, stroke, or infection, clinicians struggle to predict if they will recover.

Amyotrophic lateral sclerosis (ALS) is a disease of progressive weakness that leads to death within a few years of onset.

Mutations in the metabolic enzymes are commonly observed in brain cancers.